Date
2020-09-17Journal
BMJPublisher
BMJ Publishing GroupType
Article
Metadata
Show full item recordDescription
It seemed a truth universally acknowledged that the human population had no pre-existing immunity to SARS-CoV-2, but is that actually the case? Peter Doshi explores the emerging research on immunological responses.Keyword
Coronavirus Disease 2019 (COVID-19)COVID-19
Immunity, Herd
SARS-CoV-2--immunology
T-Lymphocytes--immunology
COVID-19 (Disease)
Identifier to cite or link to this item
http://hdl.handle.net/10713/13734ae974a485f413a2113503eed53cd6c53
10.1136/bmj.m3563
Scopus Count
Collections
Related articles
- Pre-existing immunity against Ad vectors: humoral, cellular, and innate response, what's important?
- Authors: Fausther-Bovendo H, Kobinger GP
- Issue date: 2014
- Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice.
- Authors: Croyle MA, Patel A, Tran KN, Gray M, Zhang Y, Strong JE, Feldmann H, Kobinger GP
- Issue date: 2008
- COVID-19-related conspiracy beliefs and their relationship with perceived stress and pre-existing conspiracy beliefs.
- Authors: Georgiou N, Delfabbro P, Balzan R
- Issue date: 2020 Nov 1
- COVID-19 immunity certificates: science, ethics, policy, and law.
- Authors: Greely HT
- Issue date: 2020 Jan-Jun
- Exploring mucosal immunization with a recombinant influenza virus carrying an HIV-polyepitope in mice with pre-existing immunity to influenza.
- Authors: Garulli B, Di Mario G, Stillitano MG, Kawaoka Y, Castrucci MR
- Issue date: 2014 May 1